Tegal Corporation, an innovator of specialized production solutions for the fabrication of advanced MEMS, power ICs and optoelectronic devices, today announced it has received orders for a Tegal 110 DE/SE DRIE tool and for a TEGAL SMT AlN PVD system from two prominent research centers currently equipping state-of-the-art laboratory facilities.
Shrink Nanotechnologies, Inc., an innovative platform nanotechnology company developing technologies for a number of diverse fields ranging from medical diagnostics to solar cell concentrators, announced that Heiner Dreismann, Ph.D., has joined the company's Board of Directors and will chair Shrink's Business Advisory Board. Dr. Dreismann is the former Chief Executive Officer of Roche Molecular Diagnostics, a division of F. Hoffmann-La Roche Ltd.
Raytheon Company has been awarded a $6 million contract, if all options are exercised, to develop nano thermal interface materials (nTIM) to improve the thermal performance of advanced defense electronics systems.
The report titled "Nanomedicine: A Global Strategic Business Report" announced by Global Industry Analysts, Inc., covers major market dynamics, trends, issues, and competition pertaining to the market.
A series of feasibility studies have been initiated under the direction of Professor Michael King, Ph.D. of the Department of Biomedical Engineering at Cornell University in Ithaca New York and in co-operation with CellTraffix Inc.
QD Soleil, eine Tochter der Nanostart-Beteiligung Nanosys, hat bekannt gegeben, dass das amerikanische Patentamt ihre Patentansprüche zur Nutzung von Nanostrukturen für Solarkonzentratoren anerkannt hat.
QD Soleil, the solar division of Nanosys, Inc., today announced the expansion of its leadership and advisory team including the addition of four exceptional thought leaders in the use of nanotechnology for solar energy applications.
NanoSight, manufacturers of unique nanoparticle characterization technology, are happy to report that Kaneo Chiba and Masayoshi Takahashi of Japan's famous AIST research centre are using nanoparticle tracking analysis (NTA) technology to characterize nanobubbles.
To address the challenges of wafer polishing at future technology nodes, Peter Wolters GmbH, a wholly-owned subsidiary of Novellus Systems, has recently developed advanced polishing technology for its MicroLine AC 1500-P3 and AC 2000-P3 double-sided silicon wafer polishing systems that will meet the lithography requirements for semiconductor device manufacturing at 22nm and beyond.
Calando Pharmaceuticals, Inc. has entered into a worldwide license agreement with Cerulean Pharma Inc. for Calando's drug delivery platform, Cyclosert, and associated clinical stage anti-cancer drug, IT-101.